Loading

July, 2009

  • by Allen St. Pierre, NORML Executive Director July 12, 2009

    California’s citizens and legislators may be at the vanguard of America’s progressive cannabis policy-making, but, unfortunately, many in the law enforcement community in the Golden State are still uncomfortable with–and resistive of–the will of the voters (their employers) when it comes to physician-sanctioned, patient access to medicinal cannabis.

    A ‘white paper’ released to California law enforcement (including prosecutors) in late April by the California Police Chiefs Association is just now being seen by the general public and the cannabis law reform community, and the paper once again reinforces the clear intent of the law enforcement community to continue leading the charge in maintaining the status quo of cannabis prohibition.

    By any fair measurement, law enforcement is unrivaled in serving as one of the five pillars of cannabis prohibition.

    Read the CPCA report here.

    In response, later this summer, the NORML Foundation will publish a definitive legal guide to medical cannabis for practicing lawyers and medical cannabis dispensaries. Additionally, NORML seeks to provide complimentary copies of the guide to all of the public defenders’ offices in California.

  • by Paul Armentano, NORML Deputy Director July 10, 2009

    In May I blogged under the headline “Want To Know Why Pot Is Illegal? Ask Your Governor” in response to Minnesota Republican Governor Tim Pawlenty’s decision to veto legislation that would have granted terminally ill patients the legal option to possess and use (but not grow) medicinal cannabis. It wasn’t the first time I’d written such a post and it won’t be last.

    Earlier this week I criticized Hawaii Republican Governor Linda Lingle for her refusal to approve legislation that merely sought to study “issues relating to medical cannabis patients and current medical cannabis laws.” Today we can add New Hampshire Democrat (just in case any of you out there are under the illusion that marijuana intolerance is not bipartisan) Gov. John Lynch to the list of public officials who single-handedly stand in the way of cannabis law reform.

    Governor Lynch, as many expected, vetoed legislation that would have allowed qualified patients  who had not responded to prescribed medications to possess and use (but not grow) medicinal cannabis. Lawmakers added the controversial, last-minute restrictions to the bill in an effort to gain the Governor’s support. Yet despite their best efforts, Gov. Lynch insisted upon placing political ideology before the health and welfare of his constituents.

    For those keeping score at home, Governor Lynch’s veto (which state lawmakers will attempt to override) marks the fourth time this year that a state governor has rejected a marijuana law reform measure. And why did Gov. Lynch take the action he did? I’ll let him explain:

    “I recognize that the sponsors of this legislation, and the members of the conference committee, worked hard to attempt to address the concerns raised about this legislation. … However, after consulting with representatives of the appropriate state agencies and law enforcement officials, I believe this legislation still has too many defects to move forward.”

    To translate: Cops and my Attorney General hate the notion of anyone — even the terminally ill — possessing the option to use cannabis legally under state law, and I will continue to kowtow to these special interests even if it means my constituents will have to suffer because of my ignorant and callous decision.

    Like I said before: Want To Know Why Pot Is Illegal? Ask Your Governor.

  • by Paul Armentano, NORML Deputy Director July 8, 2009

    Meet Hawaii’s Republican Governor Linda Lingle. On Monday, Gov. Lingle vetoed Senate Bill 1058, which called on the legislature to merely study “issues relating to medical cannabis patients and current medical cannabis laws.”

    Specifically, SB 1058 called for the formation of a legislative task force to:

    (1) Examine current state statutes, state administrative rules, and all county policies and procedures relating to the medical marijuana program;

    (2) Examine all issues and obstacles that qualifying patients have encountered with the medical marijuana program;

    (3) Examine all issue and obstacles that state and county law enforcement agencies have encountered with the medical marijuana program;

    (4) Compare and contrast Hawaii’s medical marijuana program with all other state medical marijuana programs; and

    (5) Address other issues and perform any other function necessary as the task force deems appropriate, relating to the medical marijuana program.

    In her veto address, Gov. Lingle alleged — laughably — that the mere act of examining the medical marijuana laws of Hawaii and a dozen other states violates federal anti-drug laws.

    “I am returning herewith, without my approval, Senate Bill No. 1058. … This bill establishes the medical cannabis task force … to review issues related to (Hawaii’s) medical marijuana program and make recommendations for any proposed legislation and rules. … The medical task force is unnecessary because it would attempt to deal with issues raised by medical marijuana users that can only be addressed by circumventing federal law.

    Keep in mind that just days earlier lawmakers in Rhode Island overwhelmingly approved legislation to allow the state to license nonprofit facilities to produce and dispense medicinal cannabis to qualified patients. Yet in Hawaii the Governor would have us believe that just gathering feedback from patients and local law enforcement regarding the state’s nearly ten-year-old medical cannabis program somehow violates federal law. It’s an absurd position and no doubt Gov. Lingle, who vetoed a similar task force bill last year, knows it.

    Of course, the true motive behind Gov Lingle’s action — and the similar actions of her fellow prohibitionists — is to silence any sort of public or political debate surrounding America’s failed marijuana policies.

    This was the motivation behind President Obama’s decision to ‘laugh off’ the issue of marijuana law reform during his online town hall this past March. Silencing free speech was also the driving force behind the actions of members of Congress who earlier this year threatened to withhold funding from the city of El Paso, Texas, if they so much as dared to hold an “honest, open national debate” regarding US drug policy. And surely this was the motivating force behind a South Dakota Judge’s decision this week to bar longtime NORML advocate Bob Newland from engaging in any public advocacy of marijuana law reform for one year. (Full disclosure: Bob Newland, under the banner of SoDakNORML, had been leading the petition drive to place a medical marijuana initiative on the 2010 state ballot. In other words, Judge Delaney’s decision isn’t simply limiting Mr. Newland’s constitutional rights to free speech, it’s also potentially limiting the voting rights of all South Dakotans.)

    (more…)

  • by Allen St. Pierre, NORML Executive Director July 7, 2009

    Hello Bob,

    I’m sorry to read of this near conclusion of your run-in with cannabis prohibition laws in SD. Like you, I’d hope to see a suspended sentence, or a lower sentence all together.

    With 98% of all criminal cases being plea bargained, I’m sure this Hobson’s Choice was a difficult one to make.

    Being banned from public advocacy regarding something you–and clearly tens of millions of other Americans agree should be discussed publicly–maybe the cruelest cut of all. One that I suspect is ironically going to draw more attention/media awareness to your ‘run-of-the-mill’ cannabis bust than any cannabis possession case in your state’s history (if it has not already).

    You may have to remain mum about marijuana advocacy (for a year), but groups like NORML never will, and where your voice has been temporarily silenced by a system (i.e., the mechanisms of cannabis prohibition) no longer worthy of public respect in America (and South Dakota), know full well that hundreds of thousands of your like-minded friends and fellow cannabis consumers will be LOUDLY protesting the continuation of cannabis prohibition from the halls of Congress, to Statehouses across the country, to the streets and parks in protest of both a failed public policy—and against any government or court mandates that seek criminal sanctions against citizens who disagree with prohibition laws, and will not allow them to share their views with the general public.

    When a simple cannabis arrest turns into government restrictions on protected First Amendment speech and right of assembly, cannabis consumers and concerned citizens need to re-double their efforts to end our country’s expensive and destructive cannabis prohibition laws.

    Godspeed Bob! Please remain in touch with NORML!!

    Cannabem liberemus,

    -Allen St. Pierre

    NORML

    On 7/6/09 9:40 PM, “Bob Newland” <newland@rapidcity.com> wrote:

    6 July 2009

    Hello everyone;

    This will be the last email I send under the banner ‘South Dakotans for Safe Access‘ at least for a year.

    By now, most of you know I plead to a felony count of possession of marijuana in May. Today I was sentenced.

    In an hour-long sentencing hearing, Judge Delaney waxed reminiscent as he described his admiration for Muhammad Ali’s stance against an illegal war, which cost him millions of dollars and his peak performing years, during which time he did not complain, nor did he leave the country that so abused him for his beliefs.

    Then, citing the fact that he (Judge Delaney) had to account for his actions to the hundreds of kids he sees in juvenile court, he sentenced me to a year in the Penn. Co. jail, with all suspended but 45 days. During the suspended part of the sentence I will wear a bracelet that senses alcohol use and I will be subject to arbitrary piss tests by a probation officer to detect illegal “drug” use. In addition I may have no “public role” in cannabis law reform advocacy during that year.

    Work release is an option, but I have few marketable skills, especially in a time when everyone else is getting laid off. I’ll follow any leads any of you might have.

    It was somewhat harsher than I expected, and probably less than I deserved. At least it did not cost me a career worth millions, and my peak performing years won’t begin until July 6, 2010. And that’s about all I feel comfortable saying about it. For a year.

    I’ll turn 61 in prison, doin’ six weeks for smokin’ a joint. Mama cried.
    *****

    I will do my time beginning sometime in August. If I have a job of the conventional sort (you know, with a time to get there and a time to leave) I can get work release. So, if you have any ideas for me along those lines?…

    Thanks again to all who sent letters to the judge, and to those who have sent messages of support to me.

    For 40 years I have watched as dozens of people I know–and thousands I know of–go through this same, ummm?, procedure. Now it’s happening to me, and I feel the same frustration over the purposelessness of it all as I have felt for all those other people, many, many, many of whom were treated far more viciously than I.

    Someday this war will be over.

    So long for now,
    Bob
    +++++++++++++++++++++++++++++++
    For anything for which email is inadequate, contact sender at
    24594 Chokecherry Ridge Rd
    Hermosa SD 57744
    605-255-4032

  • by Allen St. Pierre, NORML Executive Director

    By Dale Gieringer, Director, CA NORML

    Like many medical marijuana users, Kristin Redeen needed additional prescription medications for her severe chronic pain. For seven years she had been treated at a private pain clinic in the Central Valley, where a doctor maintained her on Percocet, a semi-synthetic opioid. One day Kristin was unexpectedly asked to submit a urine sample.  pot_civil_rights

    “They already knew about my medical marijuana use,” says Kristin, who contacted California NORML. “I didn’t think I was doing anything wrong.”

    When the test  came back, Kristin was informed that the clinic would no longer renew her prescription because she had tested positive for an illegal controlled substance. Her doctor at the clinic cited legal concerns, claiming –falsely– that DEA regulations forbid giving prescription narcotics to users of marijuana or other illegal drugs.

    Kristin was cut off from her Percocet and began suffering seizures. She finally found a physician who was willing to prescribe her another opioid, Vicodin, but only at low doses insufficient to relieve her constant pain.

    Kristin is one of a growing number of medical marijuana patients discriminated against by pain clinics. “I must have heard of 25 cases this year,” says Doug Hiatt, an attorney in Washington state. “It’s Jim Crow medicine.”

    NORML has received a surge of complaints within the last six months.  Many medical marijuana users report that they can’t find a clinic willing to take them on.  Others, like Kristin, have been abandoned by clinics that suddenly adopted aggressive drug-screening policies.

    Clinics say they are legally compelled to drug-test chronic pain patients so as to avoid liability for overdoses and diversion of prescription drugs, particularly opioids such as oxycontin –which have nothing to do with cannabis.

    Chronic pain patients have good reason to object to being denied medical access to cannabis. Chronic pain is the leading indication for medical cannabis use, accounting for 90% of the patients in Oregon’s medical marijuana program.   More than 60 studies have shown cannabinoids to be effective in pain relief, according to a compilation by the International Association of Cannabis Medicine which includes four controlled studies of smoked marijuana by California’s Center for Medicinal Cannabis Research. (more…)

  • by Allen St. Pierre, NORML Executive Director July 5, 2009

    [Editor's note: The reason why the editor of Foreign Policy magazine Moises Naim's recent column is significant is because for far too long the foreign policy community has been a willing conduit for exporting America's wrongheaded and failed cannabis prohibition around the globe. But, the American dominance of the drug policy debate has started to wane over the last 8-10 years in quarters like the United Nations, and columns like Mr. Naim's underscore the myriad reasons why America's elected policymakers need to adopt a reform mindset--notably under an Obama administration--not status quo retrenchment into an unyielding, prohibition-centric cannabis policy.]

    The American prohibition on thinking smart in the drug war

    The Washington consensus on drugs rests on two widely shared beliefs. The first is that the war on drugs is a failure. The second is that it cannot be changed.

    Americans are a can-do people. They tend to believe that if something does not work, it needs to be fixed. Unless, that is, they are talking about the war on drugs. On this politically fraught issue, Washington’s elites and, indeed, the majority of the population, believe two contradictory things. First, 76 percent of Americans think the war on drugs launched in 1971 by President Richard Nixon has failed. Yet only 19 percent believe the central focus of antidrug efforts should be shifted from interdiction and incarceration to treatment and education. A full 73 percent of Americans are against legalizing any kind of drugs, and 60 percent oppose legalizing marijuana.

    This “it doesn’t work, but don’t change it” incongruity is not just a quirk of the U.S. public. It is a manifestation of how the prohibition on drugs has led to a prohibition on rational thought. “Most of my colleagues know that the war on drugs is bankrupt,” a U.S. senator told me, “but for many of us, supporting any form of decriminalization of drugs has long been politically suicidal.”

    As a result of this utter failure to think, the United States today is both the world’s largest importer of illicit drugs and the world’s largest exporter of bad drug policy. The U.S. government expects, indeed demands, that its allies adopt its goals and methods and actively collaborate with U.S. drug-fighting agencies. This expectation is one of the few areas of rigorous continuity in U.S. foreign policy over the last three decades.

    A second, and more damaging, effect comes from the U.S. emphasis on curtailing the supply abroad rather than lowering the demand at home. The consequence: a transfer of power from governments to criminals in a growing number of countries. In many places, narcotraffickers are the major source of jobs, economic opportunity, and money for elections.

    The global economic crisis will only intensify these trends as battered economies shrink and illicit trade becomes the only way for millions of people to make a living. Mexico’s attorney general reckons that U.S. consumers buy $10 billion worth of drugs from his country’s cartels each year, a business that propelled Joaquín “El Chapo” Guzmán Loera, the leader of the Sinaloa cartel, to Forbes magazine’s latest list of the world’s billionaires. According to the U.S. Department of Defense, all that money allows the two main cartels to train, equip, and pay for a highly motivated army of 100,000 that almost equals Mexico’s armed forces in size and often outguns them. And this ascendancy of the drug cartels is a global problem. The opium trade is equal to 30 percent of Afghanistan’s legal economy, and from Burma to Bolivia, Moldova to Guinea-Bissau, drug kingpins have become influential economic and political actors.

    Fortunately, there are some signs that the blind support for prohibition is beginning to wane among key Washington elites. One surprising new convert? The Pentagon. Senior U.S. military officers know both that the war on drugs is bankrupt and that it is undermining their ability to succeed in other important missions, such as winning the war in Afghanistan. When Gen. James L. Jones, a former Marine Corps commandant and supreme allied commander in Europe, was asked last November why the United States was losing in Afghanistan, he answered: “The top of my list is the drugs and narcotics, which are, without question, the economic engine that fuels the resurgent Taliban, and the crime and corruption in the country. . . . We couldn’t even talk about that in 2006 when I was there. That was not a topic that anybody wanted to talk about, including the U.S.” Jones is now U.S. President Barack Obama’s national security advisor.

    But such views have set off fierce clashes between military commanders newly focused on creating peaceful economic opportunities for Afghan families and the U.S. drug warriors set on eradicating Afghanistan’s major cash crop at any cost. What’s more, inertia alone almost guarantees strong support for drug eradication from the massive bureaucracy that lives off the tens of billions of taxpayer dollars that have funded the war on drugs for decades. The opinions of these drug warriors are immune to data: After decades of eradication efforts around the world, neither the acreage of land used to grow drugs nor the tonnage produced has shrunk.

    But prohibition at any cost is becoming increasingly hard to defend. As the drug-fueled escalation of violence in Mexico spills across the border into the United States, the American public’s willingness to ignore or tolerate policies that don’t work is bound to decline. And the consequences of failure are already on mounting display: According to the U.S. National Drug Intelligence Center, Mexican drug cartels have established operations in 195 American cities. It is much harder to ignore the collateral damage of the war on drugs when it happens in your neighborhood.

    That is the case in many other countries where the nefarious side effects of U.S. drug policies have long been felt. Three of Latin America’s most respected former presidents, Brazil’s Fernando Henrique Cardoso, Colombia’s César Gaviria, and Mexico’s Ernesto Zedillo, recently chaired a commission that came out in favor of drastic changes in the war on drugs—including decriminalization of marijuana for personal use. The commission, on which I sat, spent more than a year reviewing the best available evidence from experts in public health, medicine, law enforcement, the military, and the economics of drug trafficking. One of the commission’s main conclusions is that governments urgently need options beyond eradication, interdiction, criminalization, and incarceration to limit the social consequences of drugs. But though smart thinkers increasingly propose confronting the drug curse as a public health crisis—more options are in the commission’s report at www.drugsanddemocracy.org—real alternatives have found no space in a policy debate stalemated between absolute prohibition and wholesale legalization.

    The addiction to a failed policy has long been fueled by the self-interest of a relatively small prohibitionist community—and enabled by the distraction of the American public. But as the costs of the drug war spread from remote countries and U.S. inner cities to the rest of society, spending more to cure and prevent than to eradicate and incarcerate will become a much more obvious idea. Smarter thinking on drugs? That should be the real no-brainer.

    Moisés Naím is editor in chief of Foreign Policy [Editor's note: emphasis in column added]

  • by Allen St. Pierre, NORML Executive Director July 3, 2009

  • by Allen St. Pierre, NORML Executive Director

    Originally published, July 1, 2009, by University of Pittsburgh Law School publication, The Jurist.

    Despite the glamorization on the hit Showtime series ‘Weeds’, flashy documentaries on CNBC delving into the business side of California’s multi-billion dollar annual cannabis industry derived from Californian’s unprecedented 13-year old legal access to medical cannabis products—qualifying patients in the state (and there are hundreds of thousands of them currently) can access high-quality medical cannabis via 24/7 vending machines in cities like Los Angeles—is Rhode Island the little state that is saying ‘yes we cannabis’ the loudest via their legislature?

    pot_civil_rights

    ‘Californication’ Of Cannabis
    While California is clearly at the vanguard of implementing major legal and policy changes in seeming conflict with the federal government’s 72-year old cannabis prohibition laws, in fact little ol’ Rhode Island is on the precipice of effectively breaking the federal government’s ban on the cultivation and sale of cannabis by joining New Mexico as the only states favoring medical cannabis laws to have state-sanctioned medical cannabis cultivators and retail outlets for qualifying medical patients.

    While there are an estimated 1,800-2,000 medical cannabis dispensaries (or in the new post Mentch parlance, cannabis wellness centers) in California alone, few of them are genuinely, legally sanctioned under state laws to sell cannabis in a retail environment. However, this blooming of cannabis wellness centers in California has happened under the full view of law enforcement, state policy makers and the public health community. Californians have ‘Main Street’ access to cannabis in many parts of the Golden State, which has evolved entirely organically—in other words, the mores and values of most Californians largely accept cannabis use, whether for recreational or medicinal purposes.

    A recent Field poll of California voters affirms this with 56% support for outright legalization.

    In Rhode Island, there is no highly refined ‘cannabis culture’, or longstanding public cannabis law reform efforts to speak of—unlike Californians that have publicly debated ‘legalizing’ cannabis on numerous statewide ballot initiatives and legislative proposals going back to the early 1970s—yet, Rhode Island’s legislators, from both parties and chambers, in opposition to the Governor and numerous federal government’s anti-drug bureaucracies (i.e., DEA, ONDCP, NIDA, DOJ, FBI, etc…) first passed a ‘self-preservation’ medical cannabis law two years ago [a ‘self-preservation’ medical cannabis model is defined as a qualified patient, for which a severely limited number of medical ailments qualify for cannabis use (i.e., Cancer, AIDS, Glaucoma, Epilepsy and MS), can legally possess or grow a small amount of cannabis; there is no legal retail access to cannabis, seeds or plant cuttings (clones)].

    The Little State That Says To Washington: ‘Yes We Cannabis!’

    However, Rhode Island legislators, only two years after passage of the original medical cannabis laws, recognized that a self-preservation model is inadequate to serve the needs of sick, dying or sense-threatened patients who need whole-smoked cannabis and edibles. Again, in full opposition to the Governor and federal agencies, overrode their second veto to establish Rhode Island as the first bona fide state to legally sanction and license third parties to cultivate and sell cannabis (in the case of Rhode Island, the recent medical cannabis legislation has provided initial approval to three medical cannabis wellness centers for the entire state). (more…)

  • by Paul Armentano, NORML Deputy Director July 2, 2009

    For far too long the federal government’s war on cannabis consumers has been a bipartisan effort.

    At worst, politicians of both political persuasions have proactively lobbied for tougher pot penalties (or actively opposed efforts to amend such laws); at best, leaders of both major parties have done nothing at all.

    When will this situation change? When the core constituency of both major political parties — Republican and Democrat — compel their leaders to make drug law reform a primary part of their legislative platforms.

    In practice, this means that Republican leaders need to know that their base cares just as much about marijuana law reform as they do about shrinking the size and scope of government. Conversely, Democrat leaders need to be made aware that their supporters are just as passionate about ending the war on cannabis consumers as they are about addressing issues like climate change and health care.

    Is this day coming?

    NORML Advisory Board Member Norm Stamper believes so. Writing today on the Huffington Post blog he proclaims, correctly, that a record number of influential progressive publications and pundits are now calling for fundamental changes in drug law reform. A quick review of conservative-leaning websites and periodicals identifies a similar trend.

    For decades conventional political wisdom has dictated that drug law reform is the so-called ‘third rail’ of mainstream politics, when in fact just the opposite is true. American voters of all political persuasions are ready to embrace common-sense marijuana policies.

    The question is now: Are they ready and willing to demand them from their political leaders?

  • by Paul Armentano, NORML Deputy Director July 1, 2009

    Much has made — by the mainstream media and others — of the claim that cannabis use causes certain types of mental illness, specifically schizophrenia and psychosis.

    Most notably perhaps, a team of researchers writing in the July 28, 2007 edition of the prestigious scientific journal The Lancet, boldly proclaimed that smoking cannabis could boost one’s risk of a psychotic episode by 40 percent or more.

    Naturally, this alarmist rhetoric received wall-to-wall coverage by the mainstream press. Even more troubling, the supposed ‘pot-and-schizophrenia’ link was one of the primary reasons cited by British PM Gordon Brown, ex-Home Secretary Jacqui Smith and others as the impetus for reclassifying cannabis (from a verbal warning to a criminal offense punishable by up to five years in jail) in the United Kingdom.

    Of course, there was a fatal flaw with The Lancet‘s argument — one that, oddly enough, every single MSM outlet failed to mention. Empirical data did not support the investigators’ hypothesis that smoking marijuana was associated with increased rates of schizophrenia or other mental illnesses among the general public — a fact that even the authors begrudgingly admitted when they declared, “Projected trends for schizophrenia incidence have not paralleled trends in cannabis use over time.”

    Which brings us to 2009.

    Two years after The Lancet‘s dire predictions, a team of researchers at the Keele University Medical School have once and for all put the ‘pot-and-mental illness’ claims to the test. Writing in a forthcoming edition of the scientific journal Schizophrenia Research, they compare long-term trends in marijuana use and incidences of schizophrenia and/or psychoses in the United Kingdom. And what do they find?

    “[T]he expected rise in diagnoses of schizophrenia and psychoses did not occur over a 10 year period. This study does not therefore support the specific causal link between cannabis use and incidence of psychotic disorders. … This concurs with other reports indicating that increases in population cannabis use have not been followed by increases in psychotic incidence.”

    Should we expect an apology — or even better, a change in policy — from the Gordon Brown regime any time soon? Or at the very least, will some sort of ‘correction’ be forthcoming from the mainstream news media?

    I wouldn’t hold my breath.

Page 3 of 41234